Anandan Palani,Xianhai Huang,Dong Xiao,Sunil Paliwal,Hon-Chung Tsui,Michelle Laci Wrobleski,Ashwin U. Rao,Cheng Wang,Sapna S. Shah,Neng-Yang Shih
申请号：
US15293962
公开号：
US20170029403A1
申请日:
2016.10.14
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A compound having the general structure shown in Formula I:or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
